Citadel Discovery

Citadel Discovery is an AI/ML driven drug discovery startup with a vision to overcome the barriers to curing diseases and promoting global well-being. The company, founded in 2021, was incorporated as a Public Benefit Corporation in November 2021, with a mission to democratize access to data and technology driving biological exploration, drug discovery, and health technologies.

The startup aims to bridge the gap between industry, academia, not-for-profit foundations, venture partners, and open/crowd-source resources to build an integrated platform for data generation and sharing. Their focus is on overcoming significant challenges in therapeutic discovery by creating a platform for sharing enabling data sets, developing a comprehensive AI platform for drug discovery, and generating high-value data sets to eliminate redundancy in the process.

Last investment was a Non-Equity Assistance investment on 08 December 2022, received from PharmStars. With headquarters in the United States and operating in the AI and Pharmaceutical industries, Citadel Discovery is poised to make a significant impact in the field of drug discovery and healthcare technologies. Their slogan, "Accelerate. De-risk, Expand" encapsulates their mission to revolutionize the drug discovery process.